Is MNKD up or down today?
MNKD is down 1.53% today, last at 3.85. This stock moved -1.53% versus the prior close.
MNKD · MNKD
MNKD (MNKD) is trading at 3.85, down 1.53% on the session. Price action and momentum indicators lean constructive.
Over the past 7 days, 34 headlines skew mixed. Macro/Market and Analyst Rating themes dominated coverage.
Social buzz is mixed — no strong crowd signal.
Analyst firms are mostly reiterating — no strong directional shift lately.
MNKD is down 1.53% today, last at 3.85. This stock moved -1.53% versus the prior close.
Over the past 7 days, 34 headlines skew mixed. Macro/Market and Analyst Rating themes dominated coverage. Dominant story: MannKind’s Inhaled IPF Drug Clears Phase 1b Safety Hurdle, Phase 2 Underway (1 source, neutral) RSI is 46 — neutral Price above 50-day average — short-term uptrend Social (demo): 41% of recent mentions lean bullish — mixed social mood.
Loaded: Feb 2026 – Jul 2026 (123 days) · Drag or scroll left for earlier dates
Analyst firms are mostly reiterating — no strong directional shift lately.
Google Trends data is temporarily unavailable — common on cloud hosts. Search interest is optional context only.
Based on 10,568 mentions over 30d
MannKind’s Inhaled IPF Drug Clears Phase 1b Safety Hurdle, Phase 2 Underway
MNKD|MannKind Corp|Price:3.855|Chg%:-0.055 - TradingKey
MannKind Reports Positive Phase 1b INFLO-1 Results, Demonstrating Safety and Tolerability of Nintedanib DPI and Clinical Validation of Its DPI Technology in IPF
Global Phase 2 Trial Is Enrolling Patients for MannKind’s Lung Drug - Stock Titan
MNKD Stock Rises 8% On Furoscix ReadyFlow Approval And $50M Funding Boost - Stocktwits